Relative Strength Chart Vertex Pharmaceuticals Incorporated

Stocks

Delayed Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
546.12 ^USD	-2.12%		+0.82%	+20.46%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	-2.12%	+0.82%	+20.46%	+37.87%	+175.75%	138B